Nasdaq

Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals

Seattle Genetics Lands $1.72B From Merck in Pair of Cancer Drug Deals

4 monthes ago   |   Xconomy

Seattle Genetics is in line to receive $1.72 billion from Merck via a pair of deals , one for a cancer drug that's still in development and the other for partial rights to a...
Read more ...

MediciNova Announces that BioComo's Intranasal RS Virus Vaccine Successfully Induced Neutralizing Antibodies against the RS Virus in Mice using BC-PIV Technology

4 monthes ago   |   San Diego Biotechnology

LA JOLLA, Calif., Sept. 11, 2020 - MediciNova, Inc., a biopharmaceutical company traded on the NASDAQ Global Market and the JASDAQ Market of the Tokyo Stock Exchange , today...
Read more ...

Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans

Now Closer to Clinical Trials, Codiak BioSciences Refiles IPO Plans

4 monthes ago   |   Xconomy

Codiak BioSciences, a company developing therapies based on tiny bubbles secreted by cells, is lining up an IPO as it prepares for the first tests of its technology in humans...
Read more ...

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

Grail Files to Go Public; 5 More Life Science Firms Join the IPO Queue

4 monthes ago   |   Xconomy

Grail, a company developing blood tests intended to detect cancer well before symptoms show, is taking its pitch to a broader swath of investors. The diagnostics company is...
Read more ...

Lixte plans Nasdaq uplisting to accelerate blood cancer trial

4 monthes ago   |   Fierce Biotech

Lixte plans Nasdaq uplisting to accelerate blood cancer trial ntaylor Fri, 09/04/2020 - 07:50
Read more ...

Athira Aims for the Nasdaq to Advance Alzheimer's Drug to Phase 2 Tests

Athira Aims for the Nasdaq to Advance Alzheimer's Drug to Phase 2 Tests

4 monthes ago   |   Xconomy

Many of the drugs tested in Alzheimer's disease so far, and some still in development, aim to block or break up proteins associated with the progression of the memory-robbing...
Read more ...

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

Dyne Eyes IPO for R&D of Genetic Medicines for Rare Muscle Diseases

4 monthes ago   |   Xconomy

Not long ago, having early data about how an experimental drug worked in humans was expected of biotechs considering IPOs. Dyne Therapeutics may not reach human testing until...
Read more ...

Qualigen Therapeutics, Inc. Announces Closing of $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

5 monthes ago   |   San Diego Biotechnology

CARLSBAD, Calif., Aug. 4, 2020 /PRNewswire/ - Qualigen Therapeutics, Inc. , today announced the closing of its previously announced registered direct offering, priced...
Read more ...

Qualigen Therapeutics, Inc. Announces $10 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules

5 monthes ago   |   San Diego Biotechnology

CARLSBAD, Calif., Aug. 2, 2020 /PRNewswire/ - Qualigen Therapeutics, Inc. , today announced it has entered into a definitive agreement with a single institutional investor for...
Read more ...

F-star set to land Nasdaq listing through Spring Bank merger

5 monthes ago   |   Fierce Biotech

F-star set to land Nasdaq listing through Spring Bank merger ntaylor Thu, 07/30/2020 - 06:04
Read more ...


Register you to post on BioTech Mag

Free Registration

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

World Biotechnology Congress 2019

Hilaris Conferences is going to host its premier World Biotechnology Congress 2019 during October 01-02, 2019, Valencia, Spain. Biotechnology 2019 Congress aim to create a... Read more ...

2nd International Conference on Tissue Science and Regenerative Medicine

This conference is designed for experts in academia and industries working in the tissue science and regenerative field, this conference will examine cutting-edge research in... Read more ...

PacBio and Invitae Team Up to Develop Ultra-High-Throughput Clinical Whole...

PacBio and Invitae Team Up to Develop Ultra-High-Throughput Clinical Whole Genome Sequencing Platform

The power of PacBio HiFi reads has enabled transformative research into human disease. A new collaboration with Invitae, a leader in medical genetics, is intended to help... Read more ...

STAT: Businesses across the vaccine supply chain must work together to make...

STAT: Businesses across the vaccine supply chain must work together to make Covid-19 vaccines

Andrey Zarur, CEO of GreenLight Biosciences, writes for STAT about the vaccine supply chain and how we need to work together to make Covid-19 vaccines. Credit: LEON NEAL/GETTY... Read more ...

IAmScience Leland Cseke

IAmScience Leland Cseke

By Becca Wolf | Bond LSC In a cluttered basement in Dearborn, Michigan, one could find Leland Cseke conducting amateur plant tissue culture experiments on his family's pool... Read more ...

Study: X-Rays Surrounding ‘Magnificent 7' May Be Traces of Sought-After Particle

Study: X-Rays Surrounding ‘Magnificent 7' May Be Traces of Sought-After Particle

An artistic rendering of the XMM-Newton space telescope. A study of archival data from the XMM-Newton and the Chandra X-ray space telescopes found evidence of high levels of... Read more ...

MendelVar: gene prioritisation at GWAS loci using phenotypic enrichment of...

AbstractMotivationGene prioritisation at human GWAS loci is challenging due to linkage disequilibrium and long-range gene regulatory mechanisms. However, identifying the causal... Read more ...

A two-step approach to testing overall effect of gene-environment...

AbstractMotivationWhile gene-environment interactions contribute importantly to many different phenotypes, detecting such interactions requires well-powered studies and has... Read more ...

A network-based deep learning methodology for stratification of tumor mutations

AbstractMotivationTumor stratification has a wide range of biomedical and clinical applications, including diagnosis, prognosis and personalized treatment. However, cancer is... Read more ...

Recognition of small molecule-RNA binding sites using RNA sequence and structure

AbstractMotivationRNA molecules become attractive small-molecule drug targets to treat disease in recent years. Computer-aided drug design can be facilitated by detecting the... Read more ...

ShinyÉPICo: a graphical pipeline to analyze Illumina DNA methylation arrays

AbstractSummaryIllumina DNA methylation bead arrays provide a cost-effective platform for the simultaneous analysis of a high number of human samples. However, the analysis can... Read more ...

PC2P: Parameter-free network-based prediction of protein complexes

AbstractMotivationPrediction of protein complexes from protein-protein interaction networks is an important problem in systems biology, as they control different cellular... Read more ...